Literature DB >> 15503433

Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

Jörg Kreuter1.   

Abstract

Poly(alkyl cyanoacrylate) nanoparticles enable the delivery of a number of drugs, including doxorubicin, loperamide, tubocurarine, the NMDA receptor antagonist MRZ 2/576, and the peptides dalargin and kytorphin across the blood-brain barrier (BBB) after coating with surfactants. However, only the surfactants polysorbate (Tween) 20, 40, 60 and 80, and some poloxamers (Pluronic F 68) can induce this uptake. The mechanism for the delivery across the BBB most likely is endocytosis via the LDL receptor by the endothelial cells lining the brain blood capillaries after injection of the nanoparticles into the blood stream. This endocytotic uptake seems to be mediated by the adsorption of apolipoprotein B and/or E adsorption from the blood. Thus, the nanoparticles could mimic lipoprotein particles and act as "Trojan Horses." The drug, then, may be released either within these cells followed by passive diffusion into the brain or be transported into the brain by transcytosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503433     DOI: 10.1166/jnn.2003.077

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  53 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 2.  Xenobiotic pulmonary exposure and systemic cardiovascular response via neurological links.

Authors:  Phoebe A Stapleton; Alaeddin B Abukabda; Steven L Hardy; Timothy R Nurkiewicz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 3.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

Review 4.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

6.  Future prospects of nanoparticles on brain targeted drug delivery.

Authors:  C Chakraborty; B Sarkar; C H Hsu; Z H Wen; C S Lin; P C Shieh
Journal:  J Neurooncol       Date:  2008-12-02       Impact factor: 4.130

7.  Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies.

Authors:  E Markoutsa; K Papadia; A D Giannou; M Spella; A Cagnotto; M Salmona; G T Stathopoulos; S G Antimisiaris
Journal:  Pharm Res       Date:  2013-12-13       Impact factor: 4.200

8.  Nanoparticle and iron chelators as a potential novel Alzheimer therapy.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  Methods Mol Biol       Date:  2010

9.  Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line.

Authors:  Niladri Chattopadhyay; Jason Zastre; Ho-Lun Wong; Xiao Yu Wu; Reina Bendayan
Journal:  Pharm Res       Date:  2008-05-31       Impact factor: 4.200

Review 10.  Deposition and biokinetics of inhaled nanoparticles.

Authors:  Marianne Geiser; Wolfgang G Kreyling
Journal:  Part Fibre Toxicol       Date:  2010-01-20       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.